Elena Piazza

1.8k total citations
31 papers, 1.3k citations indexed

About

Elena Piazza is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Elena Piazza has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Elena Piazza's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (8 papers) and Cancer therapeutics and mechanisms (5 papers). Elena Piazza is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (8 papers) and Cancer therapeutics and mechanisms (5 papers). Elena Piazza collaborates with scholars based in Italy, Chile and Denmark. Elena Piazza's co-authors include Francesco Perrone, Ciro Gallo, Luigi Manzione, Cesare Gridelli, Luciano Frontini, Santi Barbera, S. Cigolari, Sergio Robbiati, Francesco Rosetti and Paola Lusardi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Elena Piazza

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Piazza Italy 14 702 408 205 175 152 31 1.3k
Philip R. Debruyne Belgium 22 678 1.0× 453 1.1× 320 1.6× 187 1.1× 215 1.4× 87 1.6k
Jeffrey K. Giguere United States 22 1.4k 2.0× 795 1.9× 357 1.7× 185 1.1× 65 0.4× 66 2.2k
Fade Mahmoud United States 20 701 1.0× 193 0.5× 151 0.7× 306 1.7× 38 0.3× 51 1.5k
Mohamedtaki Abdulaziz Tejani United States 22 1.0k 1.5× 454 1.1× 635 3.1× 128 0.7× 40 0.3× 80 1.7k
Michelle Shayne United States 19 774 1.1× 293 0.7× 84 0.4× 159 0.9× 40 0.3× 44 1.4k
Katherine S. Garman United States 19 252 0.4× 208 0.5× 390 1.9× 127 0.7× 52 0.3× 52 1.0k
Henriette Breunis Canada 20 661 0.9× 618 1.5× 61 0.3× 195 1.1× 214 1.4× 64 1.3k
Chiara Falcone Italy 18 120 0.2× 284 0.7× 157 0.8× 67 0.4× 127 0.8× 30 1.1k
Kyuwan Lee United States 14 793 1.1× 213 0.5× 75 0.4× 411 2.3× 42 0.3× 44 1.2k
Carlos Jara Spain 20 795 1.1× 179 0.4× 131 0.6× 198 1.1× 85 0.6× 58 1.4k

Countries citing papers authored by Elena Piazza

Since Specialization
Citations

This map shows the geographic impact of Elena Piazza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Piazza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Piazza more than expected).

Fields of papers citing papers by Elena Piazza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Piazza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Piazza. The network helps show where Elena Piazza may publish in the future.

Co-authorship network of co-authors of Elena Piazza

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Piazza. A scholar is included among the top collaborators of Elena Piazza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Piazza. Elena Piazza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marco, Roberto Di, Ann Hallemans, Francesca Ragona, et al.. (2019). Gait abnormalities in people with Dravet syndrome: A cross-sectional multi-center study. European Journal of Paediatric Neurology. 23(6). 808–818. 16 indexed citations
2.
Morabito, Alessandro, Gennaro Daniele, Raffaele Costanzo, et al.. (2017). A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients. Lung Cancer. 108. 15–21. 7 indexed citations
3.
Canafoglia, Laura, Francesca Ragona, Ferruccio Panzica, et al.. (2017). Movement-activated cortical myoclonus in Dravet syndrome. Epilepsy Research. 130. 47–52. 10 indexed citations
4.
Palumbo, Raffaella, Federico Sottotetti, Giuseppe Trifirò, et al.. (2015). Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life. Drug Design Development and Therapy. 9. 2189–2189. 34 indexed citations
5.
Cortinovis, Diego, Giordano Beretta, Elena Piazza, et al.. (2013). Chemotherapy-induced anemia and oncologist perception on treatment: results of a web-based survey.. PubMed. 99(1). 45–50. 11 indexed citations
6.
Piazza, Elena, Erika Della Mina, Ivan Limongelli, et al.. (2013). Dravet phenotype in a subject with a der(4)t(4;8)(p16.3;p23.3) without the involvement of the LETM1 gene. European Journal of Medical Genetics. 56(10). 551–555. 10 indexed citations
8.
Cortinovis, Diego, Giordano Beretta, Elena Piazza, et al.. (2013). Chemotherapy-Induced Anemia and Oncologist Perception on Treatment: Results of a Web-Based Survey. Tumori Journal. 99(1). 45–50. 11 indexed citations
10.
Celio, Luigi, S. Frustaci, Angela Buonadonna, et al.. (2010). Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial. Supportive Care in Cancer. 19(8). 1217–1225. 76 indexed citations
11.
Oteri, Alessandro, María Teresa Cattaneo, V. Filipazzi, et al.. (2009). A Case of Bullous Dermatitis Induced by Erlotinib. The Oncologist. 14(12). 1201–1204. 3 indexed citations
12.
Gridelli, Cesare, Ermelinda De Maio, Santi Barbera, et al.. (2008). The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients. Lung Cancer. 61(1). 67–72. 8 indexed citations
13.
Lucini, Daniela, Valentina Cannone, Mara Malacarne, et al.. (2008). Evidence of autonomic dysregulation in otherwise healthy cancer caregivers: A possible link with health hazard. European Journal of Cancer. 44(16). 2437–2443. 31 indexed citations
14.
Maïo, Massimo Di, Cesare Gridelli, Ciro Gallo, et al.. (2005). Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials. The Lancet Oncology. 6(9). 669–677. 181 indexed citations
16.
Elli, M., et al.. (2004). Considerations on early diagnosis of carcinoma of the pancreas.. PubMed. 50(54). 2205–7. 6 indexed citations
17.
Gridelli, Cesare, Antônio Rossi, Emiddio Barletta, et al.. (2002). Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II study. Lung Cancer. 36(3). 327–332. 14 indexed citations
18.
Lusardi, Paola, et al.. (2000). Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24‐hour study. British Journal of Clinical Pharmacology. 49(5). 423–427. 77 indexed citations
20.
Piazza, Elena, María Teresa Cattaneo, Fabrizio Colombo, & A Libretti. (1984). ACTH analogue application to oncostatic chemotherapy. A double blind approach. La Ricerca in Clinica e in Laboratorio. 14(2). 257–259. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026